Skip to main page content

Amin Kherani MD

Roche Co-Developed Symposium Panellist
Participates in 23 items

Dr. Amin Kherani is a Clinical Associate Professor at the University of Calgary and Past President of the Canadian Retina Society. He is an active educator and vitreoretinal surgeon who has serviced the Calgary and Southern Alberta community for nearly 25 years. He completed most of his medical education including his MD and Ophthalmology Residency at the University of Alberta. He furthered his subspecialty fellowship training in Medical and Surgical Retina at the University of Iowa. He was the inaugural ophthalmology Residency Training Director at the University of Calgary, which he served for nearly 10 years. He is also the current Retina Fellowship Program Co-director which was initiated together with Dr. Geoff Williams in Calgary about 15 years ago. They also co-founded and developed a community-based group retina practice, Calgary Retina Consultants and built the Southern Alberta Eye Center. The Department of Surgery, Calgary zone has appointed Dr. Kherani to lead the Office of Surgical Fellowship for all surgical fellows at the University of Calgary. Complimenting is professional activities, he also engages actively in clinical research and has participates in numerous industry supported randomized clinical trials. He really enjoys playing tennis and is committed to his family including his dear wife Shellina and their two children, Jayhan and Imaan.

 Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:

  1. Abbvie
  2. Alcon
  3. Bayer
  4. Bausch + Lomb
  5. Novartis
  6. Allergan
  7. Roche
  8. Appellis
  9. Bayer
  10. Novartis
  11. Roche/Genentech
  12. Allergan/AbbVie
  13. Chengdu Kanghong
  14. Biotechnology
  15. Ophthotech
  16. Regeneron
  17. Regenexbio
  18. Iveris Bio Inc
  19. Opthea
  20. Alexion
  21. MD Collaborate

Sessions in which Amin Kherani MD participates

sexta-feira 1 junho, 2018

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
6:30
6:30 - 8:00 | 1 hour 30 minutes
Co-Developed Symposium

LEARNING OBJECTIVES:At the end of this symposium, participants will be able to:Describe the advantages and limitations of various treatment strategies for uveitis, including local and systemic therapies, and choose the most appropriate line of therapy for different uveitis presentationsIndicate the advantages and limitations of anti-VEGF agents in treating intraocular neovascularisation or macular edema secondary to uveitis vs. other vasculopathic causes of...

6:35
6:35 - 6:50 | 15 minutes
Co-Developed Symposium
7:50
7:50 - 8:00 | 10 minutes
Co-Developed Symposium
11:45

domingo 3 junho, 2018

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

sábado 15 junho, 2019

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
11:10
11:10 - 11:17 | 7 minutes
Retina

quinta-feira 9 junho, 2022

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
7:50
7:50 - 8:00 | 10 minutes
Pathology

sexta-feira 10 junho, 2022

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
9:50
9:50 - 10:00 | 10 minutes
Uveitis

Authors: Tyler J. Henry Gurkaran S. Sarohia, Natalia Figueiredo, Natalie Dougherty, Matthew Tennant, Alejandra Ugarte-Torres, Hoi Tai Fung, R. Geoff Williams, Michael Fielden, Anna Ells, Patrick Mitchell, Mark Greve, Rizwan Somani, Chad Baker, Brad Hinz, Mark Seamone, David Ehmann, Amin Kherani.Author Disclosure Block: T.J. Henry: 

sábado 11 junho, 2022

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
10:05
10:08 - 10:13 | 5 minutes
Retina

Authors: Rajinder S. Nirwan, Natalia Figueiredo, Julia Farah, Shellina Kherani, Sarah Ha, April Ingram, Geoff Williams, Amin Kherani. Author Disclosure Block: R.S. Nirwan: None. N. Figueiredo: None. J. Farah: None. S. Kherani: None. S. Ha: None. A. Ingram: None. G. Williams: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Bayer, Novartis, Roche. Funded grants or clin...

sexta-feira 16 junho, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
15:45
15:45 - 17:15 | 1 hour 30 minutes
Retina

 Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar

quinta-feira 19 junho, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
13:15
13:19 - 13:30 | 11 minutes

Additional authors: Vania Zarza, Faazil Kassam, Martin Hyrcza 

sexta-feira 20 junho, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
16:15
16:25
16:29 - 16:32 | 3 minutes
16:35
16:37 - 16:40 | 3 minutes
16:45
16:45 - 16:48 | 3 minutes
16:50
16:53 - 16:56 | 3 minutes
17:05
17:08 - 17:11 | 3 minutes
17:15
17:16 - 17:19 | 3 minutes
17:20
17:24 - 17:27 | 3 minutes
17:30
17:32 - 17:35 | 3 minutes
17:35

sábado 21 junho, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
7:00
7:00 - 8:30 | 1 hour 30 minutes
Co-Developed Symposium

Join us at this Accredited Symposium co-developed with COS and Roche! Chaired by Bernard Hurley and Cynthia Qian.The retinal care symposium is also taking shape. Drawing inspiration from "Who Wants to Be a Millionaire," we are developing an engaging game-show format where specialists tackle increasingly challeng...